Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History BLFS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics BLFS

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

BioLife Solutions Inc

BLFS
Current price
21.95 USD -0.77 USD (-3.39%)
Last closed 22.72 USD
ISIN US09062W2044
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 1 105 798 272 USD
Yield for 12 month +5.53 %
1Y
3Y
5Y
10Y
15Y
BLFS
21.11.2021 - 28.11.2021

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington. Address: 3303 Monte Villa Parkway, Bothell, WA, United States, 98021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

31.22 USD

P/E Ratio

Dividend Yield

Financials BLFS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures BLFS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+82 254 000 USD

Last Year

+143 271 000 USD

Current Quarter

+23 941 000 USD

Last Quarter

-3 424 000 USD

Current Year

+57 752 000 USD

Last Year

+46 752 000 USD

Current Quarter

+15 786 000 USD

Last Quarter

+8 271 000 USD
EBITDA -455 000 USD
Operating Margin TTM -5.09 %
Price to Earnings
Return On Assets TTM -0.79 %
PEG Ratio 65.38
Return On Equity TTM -2.52 %
Wall Street Target Price 31.22 USD
Revenue TTM 87 762 000 USD
Book Value 7.42 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 29.90 %
Dividend Yield
Gross Profit TTM 57 216 000 USD
Earnings per share -0.19 USD
Diluted Eps TTM -0.19 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY 640.00 %
Profit Margin -11.86 %

Stock Valuation BLFS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 250.00
Enterprise Value Revenue 11.47
Price Sales TTM 12.60
Enterprise Value EBITDA 370.73
Price Book MRQ 3.03

Technical Indicators BLFS

For 52 Weeks

19.10 USD 29.55 USD
50 Day MA 22.51 USD
Shares Short Prior Month 4 358 686
200 Day MA 24.50 USD
Short Ratio 7.48
Shares Short 4 471 162
Short Percent 13.54 %